FDA Approved: ACTEMRA — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approved Actemra (tocilizumab) under an Original Biologics License Application from Genentech. The approval was for the treatment of rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab)

Snippet

ORIG AP for ACTEMRA (TOCILIZUMAB)